This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2016 Sep 7:354:i4428.

doi: 10.1136/bmj.i4428.

Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance

Jessica Glen¹, Lefteris Floros¹, Chris Day², Rachel Pryke³; Guideline Development Group

Affiliations

Affiliations

¹ National Guideline Centre, Royal College of Physicians, London NW1 4LE, UK.
² Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, UK [email protected].
³ Winyates Health Centre, Redditch B98 0NR, UK.

PMID: 27605111
DOI: 10.1136/bmj.i4428

Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance

Jessica Glen et al. BMJ. 2016.

. 2016 Sep 7:354:i4428.

doi: 10.1136/bmj.i4428.

Authors

Jessica Glen¹, Lefteris Floros¹, Chris Day², Rachel Pryke³; Guideline Development Group

Affiliations

¹ National Guideline Centre, Royal College of Physicians, London NW1 4LE, UK.
² Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, UK [email protected].
³ Winyates Health Centre, Redditch B98 0NR, UK.

PMID: 27605111
DOI: 10.1136/bmj.i4428

No abstract available

PubMed Disclaimer

Comment in

Authors' reply to Tavabie.
Day C, Glen J, Floros L, Pryke R. Day C, et al. BMJ. 2016 Oct 11;355:i5436. doi: 10.1136/bmj.i5436. BMJ. 2016. PMID: 27729355 No abstract available.

Similar articles

Diagnosis and Management of Nonalcoholic Fatty Liver Disease.
Paul S, Davis AM. Paul S, et al. JAMA. 2018 Dec 18;320(23):2474-2475. doi: 10.1001/jama.2018.17365. JAMA. 2018. PMID: 30476962 No abstract available.
Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.
Athyros VG, Tziomalos K, Katsiki N, Doumas M, Karagiannis A, Mikhailidis DP. Athyros VG, et al. World J Gastroenterol. 2015 Jun 14;21(22):6820-34. doi: 10.3748/wjg.v21.i22.6820. World J Gastroenterol. 2015. PMID: 26078558 Free PMC article. Review.
Position statement on the diagnosis and management of non-alcoholic fatty liver disease.
Alswat KA, Fallatah HI, Al-Judaibi B, Elsiesy HA, Al-Hamoudi WK, Qutub AN, Alturaify N, Al-Osaimi A. Alswat KA, et al. Saudi Med J. 2019 Jun;40(6):531-540. doi: 10.15537/smj.2019.6.23980. Saudi Med J. 2019. PMID: 31219486 Free PMC article.
[New guidelines for NAFLD – a Swedish perspective].
Hagström H, Hoffstedt J, Reynisdottir S. Hagström H, et al. Lakartidningen. 2017 Feb 17;114:EFMD. Lakartidningen. 2017. PMID: 28221405 Swedish.
Hot Topics in Primary Care: Diagnosis of Cirrhosis and Evaluation of Hepatic Encephalopathy: Common Errors and Their Significance for the PCP.
Flamm SL. Flamm SL. J Fam Pract. 2017 Apr;66(4 Suppl):S34-S39. J Fam Pract. 2017. PMID: 28375406 Review.

See all similar articles

Cited by

Recent developments in non-invasive methods for assessing metabolic dysfunction-associated fatty liver disease.
Singh A, Sohal A, Batta A. Singh A, et al. World J Gastroenterol. 2024 Oct 21;30(39):4324-4328. doi: 10.3748/wjg.v30.i39.4324. World J Gastroenterol. 2024. PMID: 39492822 Free PMC article. Review.
Current strategies for nonalcoholic fatty liver disease treatment (Review).
Sun J, Jin X, Li Y. Sun J, et al. Int J Mol Med. 2024 Oct;54(4):88. doi: 10.3892/ijmm.2024.5412. Epub 2024 Aug 12. Int J Mol Med. 2024. PMID: 39129305 Free PMC article. Review.
Non-alcoholic fatty liver disease and the risk of urolithiasis: A systematic review and meta-analysis.
Qin S, Wang S, Wang X, Wang J. Qin S, et al. Medicine (Baltimore). 2018 Aug;97(35):e12092. doi: 10.1097/MD.0000000000012092. Medicine (Baltimore). 2018. PMID: 30170429 Free PMC article. Review.
Dynamic Chronological Changes in Serum Triglycerides Are Associated With the Time Point for Non-alcoholic Fatty Liver Disease Development in the Nationwide Korean Population Cohort.
Rim JH, Youk T, Gee HY, Cho J, Yoo J. Rim JH, et al. Front Med (Lausanne). 2021 Mar 10;8:637241. doi: 10.3389/fmed.2021.637241. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33777980 Free PMC article.
Noninvasive proteomic biomarkers for alcohol-related liver disease.
Niu L, Thiele M, Geyer PE, Rasmussen DN, Webel HE, Santos A, Gupta R, Meier F, Strauss M, Kjaergaard M, Lindvig K, Jacobsen S, Rasmussen S, Hansen T, Krag A, Mann M. Niu L, et al. Nat Med. 2022 Jun;28(6):1277-1287. doi: 10.1038/s41591-022-01850-y. Epub 2022 Jun 2. Nat Med. 2022. PMID: 35654907 Free PMC article.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information